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Congenital Zika Syndrome (CZS) occurs in up to 42% of individuals exposed to ZIKV
prenatally. Deregulation in gene expression and protein levels of components of the p53
signaling pathway, such as p53 and MDM2, due to ZIKV infection has been reported.
Here, we evaluate functional polymorphisms in genes of the p53 signaling pathway as risk
factors to CZS. Forty children born with CZS and forty-eight children exposed to ZIKV, but
born without congenital anomalies were included in this study. Gestational and
sociodemographic information as well as the genotypic and allelic frequencies of
functional polymorphisms in TP53, MDM2, MIR605 and LIF genes were compared
between the two groups. We found children with CZS exposed predominantly in the
first trimester and controls in the third trimester (p<0.001). Moreover, children with CZS
were predominantly from families with a lower socioeconomic level (p=0.008). We did not
find a statistically significant association between the investigated polymorphisms and
development of CZS; however, by comparing individuals with CZS and lissencephaly or
without lissencephaly, we found a significative difference in the allelic frequencies of the
TP53 rs1042522, which is associated with a more potent p53-induced apoptosis
(p=0.007). Our findings suggest that the TP53 rs1042522 polymorphism should begy | www.frontiersin.org July 2021 | Volume 11 | Article 6414131
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Frontiers in Cellular and Infection Microbiolobetter investigate as a genetic risk factor for the development of lissencephaly in children
with CZS.Keywords: congenital abnormalities, Zika virus infection, teratogens, genetic polymorphism, disease susceptibility,
risk factors, apoptosis, lissencephalyINTRODUCTION
Zika virus (ZIKV) is a human teratogen that infects neural cells of
children exposed during pregnancy and causes a spectrum of
multiple congenital anomalies named Congenital Zika Syndrome
(CZS), which includes microcephaly, brain calcifications,
lissencephaly, ventriculomegaly, ocular alterations, among others
(del Campo et al., 2017). It has been reported that up to 42% of all
individuals exposed to ZIKV during pregnancy indeed develop the
CZS (Nithiyanantham and Badawi, 2019).
Recently, in silico and in vitro studies have shown that the p53
protein, encoded by the TP53 gene, is differentially expressed in
human neuroprogenitor cells (hNPCs) during ZIKV infection (El
Ghouzzi et al., 2016; Zhang et al., 2016). Importantly, the increase
in the TP53 expression under this condition induce cell cycle arrest
and death of developing neurons, and it has been proposed as a
possible mechanism for ZIKV teratogenesis (El Ghouzzi et al.,
2016; Bhagat et al., 2018). Through a systems biology approach, it
was identified that p53 is the central protein of a genetic regulatory
network of proteins associated with the ZIKV infection and those
associated with microcephaly occurrence (Teng et al., 2017). In
addition, it was demonstrated that increased p53 activity leads to
an increased death rate of neural cells due to the binding of the
ZIKV capsid protein to MDM2 protein, decreasing its activity as
one of the main p53 negative regulators (Teng et al., 2017).
In a context of wild-type TP53 sequence, constitutive p53
protein levels and activity can be modulated directly or indirectly
by several regulator proteins and specific microRNAs (miRNAs)
(Liu and Chen, 2006; Hermeking, 2012). LIF, a cytokine encoded
by the LIF gene, is a p53 regulator that can both indirectly repress
p53 functions in human cells through the induction of MDM2,
or it can be up-regulated by p53 itself (Liu et al., 2015). Like p53,
LIF protein appears to be increased in brain cells infected by
ZIKV (Bayless et al., 2016). Recently, the role of miRNAs has
been described in ZIKV infection, and dysregulation of nervous
system development pathways mediated by several miRNAs was
demonstrated (Bhagat et al., 2018). The miR-605 is an miRNA
that acts as an indirect modulator of TP53 gene expression
through the negative regulation that it exerts targeting MDM2
transcripts (Xiao et al., 2011).
Based on previous evidence of differential susceptibility to ZIKV
teratogenesis in humans, as well as possible involvement of the p53
signaling pathway in this outcome, we investigated the role of
functional single nucleotide variants (SNVs) in genes of the p53
signaling pathway as potential susceptibility factors to CZS in a
sample of Brazilian children exposed to ZIKVduring pregnancy. In
addition, we evaluated the impact of ZIKV infection on the
expression of genes of this pathway in neuroprogenitor cells, the
main targets of ZIKV in the developing brain.gy | www.frontiersin.org 2MATERIALS AND METHODS
Ethical Issues
This study was carried out following the rules of the Declaration of
Helsinki and approved by the Ethics and Research Committee of
the Hospital de Clıńicas de Porto Alegre, institution responsible
for this study (n° 170619 – CAAE 78735817910015327), and by all
participating institutions. All legal guardians of individuals
recruited for this study gave their informed consent for
inclusion before they participated in the study.
Sample
This case-control study was conducted with 88 children exposed to
the ZIKV infection during pregnancy. Forty children were born
with CZS and 48 were born without congenital anomalies.
Recruitment for the study required evidence of ZIKV exposure,
defined as a positive result in theRT-PCR test to detect viral RNAor
typical symptomsof infection (e.g. rash, fever and joint pain)during
any time of the pregnancy. Patients in the CZS group (n=40) were
recruited from reports of microcephaly in five Brazilian research
and/or assistance centers: North region (Fundação Hospital das
Clıńicas doAcre, n=4),Northeast (UniversidadeEstadual doCeará,
n=21),Midwest (Universidade do Estado deMatoGrosso, n=2 and
Hospital Universitário Júlio Müller, n=12) and South (Hospital de
Clıńicas de Porto Alegre, n=1). Control group was recruited in the
same centers from the North region (n=1), Midwest (n=46, from a
cohort of women that gave birth in 2016, in the city of Tangará da
Serra) and South (n=1) of the country.
Sociodemographic and pregnancy characteristics were
obtained from questionnaires answered by mothers during
medical consultation. Clinical data (dysmorphological features
and, when available, the results of the neuroimaging and
ophthalmological exams) were obtained from chart review and
direct consultation and interviews done by physicians.
Genetic Analysis
Blood or saliva samples were collected from participants and the
DNA extraction was performed using FlexiGene DNA (Qiagen®)
or Oragene (DNA Genotek) kits. Functional single nucleotide
variants (SNVs) in TP53, MDM2, MIR605 and LIF were selected
based on their previous description as important modulators of
the p53 pathway genes, either through control of expression
levels or function of proteins (Dumont et al., 2003; Bond et al., 2004;
PimandBanks, 2004; Id Said andMalkin, 2015;Moudi et al., 2020).
Genotyping was performed using the TaqMan®Genotyping Assay
method in a Step One Plus™ Real-Time PCR System (Applied
Biosystems, Carlsbad, USA). The reference SNV numbers included
in our analyses, the commercial assay codes of TaqMan® probes
employed, and the allelic discrimination of each probe were asJuly 2021 | Volume 11 | Article 641413
Gomes et al. Genetic Susceptibility to ZIKV Teratogenesisfollows: TP53 rs1042522 [C/G] (c:2403545_10),MDM2 rs2279744
[T/G] (c:15968533_20),MIR605 rs2043556 [C/T] (c:11737438_10)
and LIF rs929271 [G/T] (c:7545904_10). The allelic and genotypic
frequencies were determined based on the genotyping results of
eachgroup. For allelic frequencies, thenumberof times anallelewas
identified in each group (case or control) was divided by the total
number of alleles present in eachgroup for eachpolymorphism (e.g.
for 40 individuals in the case group, we had a total of 80 alleles for
each polymorphism). The allelic frequencies obtained for each
group were compared with the frequencies reported in the
Brazilian population (based on the AbraOM database - http://
abraom.ib.usp.br/) and in populations all over the world (based on
the Genome Aggregation Database (gnomAD) and 1000 Genomes
Project data obtained from Ensembl database - https://www.
ensembl.org/index.html). Since the Brazilian population is highly
admixed and the individuals in this sample come from different
regions of Brazil, we decided not to compare the allelic frequencies
with a specific population (e.g. European or Latin American
populations), but with data from the world population.
Statistical Analyses
Descriptive analysis of the congenital anomalieswasperformed in the
CZS group. Quantitative variables were tested through the Shapiro-
Wilk test to verify their normality and from this, Student’s t test or
Mann–WhitneyU testwere applied to compared the groups.Hardy-
Weinberg equilibrium was tested for all SNVs. Categorical variables
werecomparedbetweengroupsbyChi-squaredTestorFisher’sExact
Test. A p-value <0.05 was considered statistically significant. The
SPSS® v.20 software (SPSS Inc., Chicago, USA) was used for data
handling and for all statistical analyses.
Gene Expression Analyses
In order to better understand the effect of ZIKV infection on the
gene expression of TP53, MDM2, MIR605 and LIF, the
expression data of human neuroprogenitor cells exposed and
not exposed to ZIKV were evaluated. For this evaluation, the raw
data from the study GSE129180 (Liu et al., 2019), available in the
Gene Expression Omnibus (GEO) database, were obtained
(https://www.ncbi.nlm.nih.gov/geo/). Supplementary Table 1
presents the characteristics of this study.
Raw data from RNA-seq analysis were downloaded from the
European Nucleotide Archive (ENA) database (https://www.ebi.
ac.uk/ena/browser/home) in.fastq format and re-processed. The
quality control of the samples was evaluated by FastQC tool
v.0.11.7 (Andrews, 2010) and they were processed in the Galaxy
platform (Afgan et al., 2018). Reads were aligned against the
human genome reference sequence (GRCh38) using the short-
read aligner Bowtie v1.2.0 or Bowtie2 v2.3.4.3 (Langmead, 2010;
Langmead and Salzberg, 2012). The read count was performed
with HTseq-count v.0.9.1 (Anders et al., 2015) to estimate the
abundance of transcripts expression. The generated outputs were
downloaded to be evaluated.
Differential gene expression analysis was performed in R v.3.6.2
applying robust multiaverage (RMA) normalization and using
limma package (Ritchie et al., 2015). ZIKV infected cells were
compared to non-infected cells. Genes with | log2 (fold change) | >Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 31.5 or <1.5 and false discovery rate (FDR) <0.05 were considered
to be statistically significant and differentially expressed.RESULTS
The clinical and sociodemographic description of the sample used
in this study was previously performed in another study by our
group (Gomes et al., 2021).However,we summarize here inTable 1
the clinical, gestational, and sociodemographic characteristics of
both study groups. Mothers of children with CZS had ZIKV
infection predominantly in the first trimester of pregnancy (80%)
while mothers of children without congenital anomalies reported
infection predominantly in the third trimester (44%) (p<0.001).
Mothers of children with CZS exhibited a lower educational level
(p<0.001) and lowermonthly family incomes compared tomothers
of children without congenital malformations (p=0.008). Children
without CZS had higher weight, height and cephalic perimeter
measures compared to with CZS.
Congenital anomalies observed in children with CZS also
were previously described in the aforementioned study (Gomes
et al., 2021), but they are summarized in Figure 1. Detailed
dysmorphologic, ocular and imaging exams were not carried out
on all individuals with CZS, since some research and assistance
centers had limited resources to perform such tests. The most
prevalent clinical findings were microcephaly (n=40, 100%)
brain calcifications (n=2/24, 92%), cerebral atrophy (n=11/12,
92%), lissencephaly (n=10/12, 83%), craniofacial disproportion
(n=15/18, 83%), ventriculomegaly (n=8/11, 73%), and ocular
alterations (n=22/32, 69%).
Figure 2 provides a summary of the proposed relationships
among genes and SNVs studied here and their interplay in
regulating the p53 pathway. Regarding the allelic and
genotypic frequencies of the SNVs selected in TP53, MDM2,
MIR605 and LIF, they were not statistically different between
CZS and control groups (Supplementary Table 2). Comparing
the allelic frequencies obtained in the case and control groups
with the frequencies reported in the Brazilian and worldwide
population, we observed that they were quite similar
(Supplementary Table 2), but it is important to note that the
Brazilian population is highly admixed (Kehdy et al., 2015), and
the allelic and genotypic frequencies of the our population are
not always similar to other specific populations.
Allelic frequencies were also compared, within the group of
children with CZS, between those who presented or not specific
brain malformations, such as intracranial calcification,
lissencephaly, cerebral atrophy, hydrocephaly and ocular
alterations (information available for more than 12 individuals)
(Supplementary Table 3). A significative difference in the allelic
frequencies of the SNV TP53 rs1042522 was found between
individuals with CZS and lissencephaly or without lissencephaly.
Interestingly, we detected the G allele with a frequency lower than
expected in individuals with lissencephaly and much higher than
expected in individuals without lissencephaly (p=0.007) (Table 2).
Genotypic frequencies were also different between groups, but this
difference was tangential to the significance.July 2021 | Volume 11 | Article 641413
Gomes et al. Genetic Susceptibility to ZIKV TeratogenesisGene expression analysis showed an increased expression of LIF
in human neuroprogenitor cells three days after the infection by the
Asian strain of ZIKV, but this association lost its significance after
correcting the p-value (logFC = 1.41, p = 0.001, FDR = 0.44). The
other genes did not have their expression disturbed by the ZIKV
infection (Supplementary Table 4).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4DISCUSSION
The ability of ZIKV to impair the central nervous system
development is still poorly understood. Although it is known that
only up to 42% of individuals exposed to ZIKV develop CZS, genetic
components related to this susceptibilityhavenotyetbeenrecognizedTABLE 1 | Evaluation of clinical, gestational, and sociodemographic characteristics in the case (CZS) and control (without CZS) groups.
Variables Casesa (n=40) Controls (n=48) p-valueb
Sex (n, %)
Male 23 (57%) 26 (54%) 0.754
Female 17 (43%) 22 (46%)
Ethnicity (n, %)
Black 31 (77%) 31 (65%) 0.242
White 9 (23%) 17 (35%)
Weight (kg) 2.5 (2.2 - 2.9) 3.2 (2.8 - 3.5) <0.001*
Height (cm) 45.0 (44.0 - 48.0) 49.0 (47.0 - 50.0) 0.001*
Cephalic perimeter (cm) 29.0 (27.3 - 31.0) 35.0 (34.0 - 36.0) <0.001*
Gestational age at birth (weeks) 38.0 (37.0 - 39.0) 38.0 (37.0 - 38.7) 0.522
Types of delivery (n, %)
Vaginal delivery 16/30 (53%) 5 (10%) <0.001*
Cesarean section 14/30 (47%) 43 (90%)
Mother’s age (years) 28.0 (22.5 - 35.5) 29.5 (22.0 - 33.0) 0.824
Father’s age (years) 28.0 (24.0 - 37.8) 31.0 (26.0 - 35.0) 0.693
Trimester of ZIKV infection (n, %)
1st 24/30 (80%) 13 (27%) <0.001*
2nd 4/30 (13%) 14 (29%)
3rd 2/30 (7%) 21 (44%)
Exposure during pregnancy (n, %)
Alcohol 3/35 (9%) 14 (29%) 0.028*
Smoke 0/35 1 (2%) 1.000
Recreational drugs 0/35 1 (2%) 1.000
Maternal yellow fever vaccine (n, %) 18/24 (75%) 35 (73%) 1.000
Maternal educational level (n, %)
Elementary school 13/38 (34%) 0 <0.001*
High school 13/38 (34%) 2 (4%)
Incomplete or complete higher education 12/38 (32%) 46 (96%)
Monthly family income (n, %)
Less than 3 minimum wages 23/27 (85%) 12/25 (46%) 0.008*
Between 3 and 9 minimum wages 4/27 (15%) 12/25 (46%)
More than 9 minimum wages 0 2/25 (8%)July 2021 | Volume 11 | ArticaIn the case group, some informations were not available or were not answered for all mothers; bQuantitative variables were compared between the groups through the
Student’s t test or Mann–Whitney U test and categorical variables through the Chi-squared test or Fisher’s exact test; Quantitative variables are presented as median and
quartiles; *Statistically significant.FIGURE 1 | Clinical characterization of children with Congenital Zika Syndrome (CZS) included in this study. ID, patient identifier; (+), Presence of the congenital
anomaly in the children; (-), Absence of the congenital anomaly in the children; Blank spaces, Without information.le 641413
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role of selected SNVs in p53 pathway genes as potential susceptibility
factors to CZS in a sample of Brazilian children exposed to ZIKV
during pregnancy. Besides, we evaluated how ZIKV infection
deregulates the expressionof the samegenes inneuroprogenitor cells.
The p53 signaling pathway was chosen for investigation in
this study because it has been shown to be affected by ZIKV
during infection (El Ghouzzi et al., 2016; Tang et al., 2016; Teng
et al., 2017). Similarly, the dysregulation of miRNAs in human
neuronal cells during ZIKV infection has also been reported by
several studies (Bhagat et al., 2018). Considering these findings
and the well-documented miRNA network acting in the direct
and indirect regulation of the p53 pathway, we also evaluated in
this work an SNV in a miRNA that has been shown to positively
regulate p53 activity (Xiao et al., 2011; Hermeking, 2012).
Although we did not find an association between the studied
SNVs and susceptibility to CZS, we found a lower frequency ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5individuals with CZS and lissencephaly carrying the G-allele of the
TP53 rs1042522 while children without lissencephaly had this
allele in homozygosis. Lissencephaly comprises a group of
disorders characterized by an abnormally smooth surface of the
cerebral cortex due an abnormal neuronal migration, where genes
related to the neural migration process are usually mutated
(Mochida, 2009). The G-allele of the TP53 rs1042522 has been
associated with higher p53 activity and more potent capacity to
induce apoptosis (Dumont et al., 2003). During ZIKV infection,
p53 expression has already been shown to be upregulated in an
attempt to decrease viral proliferation and eliminate the virus (El
Ghouzzi et al., 2016; Tang et al., 2016). In this context, individuals
carrying the G allele could have an advantage in viral elimination,
with more efficient apoptosis, while those carrying the C allele
would allow the virus to spread on a larger scale, impairing the
differentiation and activity of a greater number of neural cells.
Despite being biologically consistent with the development of an
altered phenotype, such as lissencephaly, this result should be
interpreted with caution, since this association was identified in a
small subset of patients. Therefore, additional case-control studies
with a larger sample size and extensive clinical characterization are
required to confirm this finding.
The ability of ZIKV infection to affect the expression of p53
pathway genes (El Ghouzzi et al., 2016; Zhang et al., 2016) was
one of the main reasons that led to the development of this study.
Thus, to evaluate how ZIKV affected the expression of TP53,
MDM2, MIR605 and LIF in hNPCs, we performed an analysis of
differential gene expression in exposed cells compared to
unexposed cells. The study used for such analysis (Liu et al.,FIGURE 2 | Role of the investigated genes and their functional polymorphisms in the p53 signaling pathway. The regulatory role of the proteins encoded by these
genes in the expression of the other genes in the p53 signaling pathway is represented by dark arrows. The regulatory role of the polymorphisms in their gene
expression is represented by gray arrows. Ultimately, the effect of these genetic variants on p53 expression levels and activity in the context of human neural cells
infected by ZIKV is represented. hNPCs, human neuroprogenitor cells. Created in BioRender.com.TABLE 2 | Allelic and genotypic frequencies of TP53 rs1042522 polymorphism














C 16 (80%) 0 0.007*
G 4 (20%) 4 (100%)
CC 7 (70%) 0 0.061
GC 2 (20%) 0
GG 1 (10%) 2 (100%)aClinical information was not available for all individuals with CZS. *Statistically significant.July 2021 | Volume 11 | Article 641413
Gomes et al. Genetic Susceptibility to ZIKV Teratogenesis2019 – GSE129180) was different from those cited as a reference
previously (El Ghouzzi et al., 2016 – GSE78711; Zhang et al.,
2016 – GSE80434). In this analyze, we found only the
upregulation of LIF due to ZIKV infection, not corroborating
the previously reported findings on TP53 and MDM2 (El
Ghouzzi et al., 2016; Zhang et al., 2016) and not identifying an
alteration in the MIR605 expression. However, it is important to
mention that although the cell type evaluated by these three
studies was the same (hNPCs), the differences in the lineage of
the ZIKV(Asian or African) and the time of exposure to ZIKV
have a strong influence in which genes are affected and how
significant is the altered expression. In this sense, we saw that in
the study by El Ghouzzi and colleagues (2016) the analysis of the
differential gene expression occurred 72 hours after infection by
the Asian strain of ZIKV, while in the study by Zhang et al. and
colleagues (2016) the evaluation was 64 hours after infection by
the Asian strain, and in the study by Liu et al. (2019) the analysis
occurred 3 days (72h) and 6 days after infection by the Asian
lineage, which means that no study has used the same
methodological approaches and, consequently, different results
can be expected.
Regarding the gestational and socio-environmental features, the
first trimester of ZIKV infection has been associated with the
development of more severe congenital anomalies and abortions,
while the socioeconomic level, closely related to nutritional and
health conditions, could be discussed as a possible risk factor for
ZIKV teratogenesis (França et al., 2016; Barbeito-Andrés et al.,
2020). In this sense, our study corroborated thepreviousfindingson
increased risk to CZS due to ZIKV exposure during the first
trimester (França et al., 2016). In addition, our findings suggest
that socioeconomic level may be an important risk factor, which
deserves tobe further explored in the context ofZIKVteratogenesis.
Lastly, this study has some limitations that must be
considered in the interpretation of the results, such as the
sample size, which affects our power to identify strong
associations or to perform more robust statistical analyses. The
size of our complete sample is small (n = 88) and when subgroup
comparisons are made, it becomes even smaller. Thus,
considering our sample size and based on studies that have
already performed comparisons of allelic frequencies of
polymorphisms in samples of individuals exposed to ZIKV
during pregnancy (Santos et al., 2019; Gomes et al., 2021), the
power of the present study to identify significant associations was
approximately 40%. In this sense, we highlight the importance of
future studies being carried out on larger samples, making it
possible to confirm the associations found by this study, as well
as carrying out more robust statistical analyzes, such as the allele
size effect. Currently, it is especially difficult to increase the
sample size, since fortunately the ZIKV outbreak in Brazil has
decreased since 2017. However, it is important to emphasize that
this is one of the most largest cohort of children exposed to ZIKV
during pregnancy used in the context of studies on genetic
susceptibility to ZIKV teratogenesis (Caires-Júnior et al., 2018;
Candelo et al., 2019; Santos et al., 2019; Aguiar et al., 2020;
Gomes et al., 2021). The lack of detailed data on gestational
history and clinical description for some patients is also aFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6limitation of this study, motivated by the regional variations in
available resources during medical consultation. The different
origin of the CZS and control groups may also constitute a
confounding factor in the study, because the number of cases
from each Brazilian region was not matched with the same
number of controls for the same region, and, considering that the
Brazilian population is a very admixed, it is reasonable to
speculate that differential genetic variability between groups
might have been observed for that reason and may not strictly
related to the development of CZS.
In conclusion, although some studies have described that p53
pathway genes seems to be affected by ZIKV infection and they
need attention given to their essential functions in embryonic
and fetal development and apoptosis, in the present study we did
not find any association between selected variants in genes of this
pathway and an increased risk to ZIKV teratogenesis.
Importantly, we identified a possible association between TP53
rs1042522 and the occurrence of lissencephaly in CZS patients,
which should be further explored in additional studies. We
emphasize that, although biological pathways involved in the
teratogenesis of ZIKV have been reported in recent years,
additional efforts are still needed to elucidate the main genetic
factors implicated in the susceptibility to CZS. Additional case-
control and functional studies focusing on both SNVs located in
p53 pathway genes and in specific miRNA genes regulating
ZIKV-mediated teratogenesis should be performed on
individuals exposed to ZIKV in order to better understand
their role in the CZS development.DATA AVAILABILITY STATEMENT
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